BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Göbel A, Rauner M, Hofbauer LC, Rachner TD. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology. Biochim Biophys Acta Rev Cancer 2020;1873:188351. [PMID: 32007596 DOI: 10.1016/j.bbcan.2020.188351] [Cited by in Crossref: 24] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Zou Y, Zhang H, Bi F, Tang Q, Xu H. Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy. Front Oncol 2022;12:938502. [DOI: 10.3389/fonc.2022.938502] [Reference Citation Analysis]
2 Pan K, Hu B, Wang L, Yuan J, Xu W. STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells. J Mol Neurosci 2022. [PMID: 35939202 DOI: 10.1007/s12031-022-02051-5] [Reference Citation Analysis]
3 Liu X, Zhang P, Xu J, Lv G, Li Y. Lipid metabolism in tumor microenvironment: novel therapeutic targets. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02645-4] [Reference Citation Analysis]
4 You W, Ke J, Chen Y, Cai Z, Huang ZP, Hu P, Wu X. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma. Front Immunol 2022;13:864244. [PMID: 35720314 DOI: 10.3389/fimmu.2022.864244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cui M, Yi X, Zhu D, Wu J. The Role of Lipid Metabolism in Gastric Cancer. Front Oncol 2022;12:916661. [DOI: 10.3389/fonc.2022.916661] [Reference Citation Analysis]
6 Zhen Y, Chen Y, Ge L, Wei W, Wang Y, Hu L, Loor JJ, Wang M, Yin J. The Short-Day Cycle Induces Intestinal Epithelial Purine Metabolism Imbalance and Hepatic Disfunctions in Antibiotic-Mediated Gut Microbiota Perturbation Mice. IJMS 2022;23:6008. [DOI: 10.3390/ijms23116008] [Reference Citation Analysis]
7 Sun J, Liu C, Zhong X, Xu J, An Y, Xu M, Hu J, Zhang Z, Xia Q, Wang S. Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies. Front Oncol 2022;12:887854. [DOI: 10.3389/fonc.2022.887854] [Reference Citation Analysis]
8 Laka K, Makgoo L, Mbita Z. Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions. Front Genet 2022;13:841639. [DOI: 10.3389/fgene.2022.841639] [Reference Citation Analysis]
9 Wang SY, Hu QC, Wu T, Xia J, Tao XA, Cheng B. Abnormal lipid synthesis as a therapeutic target for cancer stem cells. World J Stem Cells 2022; 14(2): 146-162 [DOI: 10.4252/wjsc.v14.i2.146] [Reference Citation Analysis]
10 Huang J, Wang J, He H, Huang Z, Wu S, Chen C, Liu W, Xie L, Tao Y, Cong L, Jiang Y. Close interactions between lncRNAs, lipid metabolism and ferroptosis in cancer. Int J Biol Sci 2021;17:4493-513. [PMID: 34803512 DOI: 10.7150/ijbs.66181] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Fu Y, Zou T, Shen X, Nelson PJ, Li J, Wu C, Yang J, Zheng Y, Bruns C, Zhao Y, Qin L, Dong Q. Lipid metabolism in cancer progression and therapeutic strategies. MedComm (2020) 2021;2:27-59. [PMID: 34766135 DOI: 10.1002/mco2.27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
12 Ishikawa T, Osaki T, Sugiura A, Tashiro J, Warita T, Hosaka YZ, Warita K. Atorvastatin preferentially inhibits the growth of high ZEB-expressing canine cancer cells. Vet Comp Oncol 2021. [PMID: 34657361 DOI: 10.1111/vco.12778] [Reference Citation Analysis]
13 Laudanski K. Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression. Int J Mol Sci 2021;22:10517. [PMID: 34638860 DOI: 10.3390/ijms221910517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Afshari AR, Mollazadeh H, Henney NC, Jamialahmad T, Sahebkar A. Effects of statins on brain tumors: a review. Seminars in Cancer Biology 2021;73:116-33. [DOI: 10.1016/j.semcancer.2020.08.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
15 Jiang W, Hu JW, He XR, Jin WL, He XY. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res 2021;40:241. [PMID: 34303383 DOI: 10.1186/s13046-021-02041-2] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
16 Baranyi M, Buday L, Hegedűs B. K-Ras prenylation as a potential anticancer target. Cancer Metastasis Rev 2020;39:1127-41. [PMID: 32524209 DOI: 10.1007/s10555-020-09902-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
17 Paudel R, Fusi L, Schmidt M. The MEK5/ERK5 Pathway in Health and Disease. Int J Mol Sci 2021;22:7594. [PMID: 34299213 DOI: 10.3390/ijms22147594] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
18 Ahmed N, Kidane B, Wang L, Nugent Z, Moldovan N, McElrea A, Shariati-Ievari S, Qing G, Tan L, Buduhan G, Srinathan SK, Aliani M. Metabolic Changes in Early-Stage Non-Small Cell Lung Cancer Patients after Surgical Resection. Cancers (Basel) 2021;13:3012. [PMID: 34208545 DOI: 10.3390/cancers13123012] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Patel KK, Kashfi K. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem Pharmacol 2021;:114654. [PMID: 34129857 DOI: 10.1016/j.bcp.2021.114654] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
20 Ortiz N, Delgado-Carazo JC, Díaz C. Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells. Clin Exp Gastroenterol 2021;14:217-28. [PMID: 34103960 DOI: 10.2147/CEG.S310235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Lasunción MA, Martínez-Botas J, Martín-Sánchez C, Busto R, Gómez-Coronado D. Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids. Biochem Pharmacol 2021;:114623. [PMID: 34052188 DOI: 10.1016/j.bcp.2021.114623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tilija Pun N, Jeong CH. Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance. Pharmaceuticals (Basel) 2021;14:470. [PMID: 34065757 DOI: 10.3390/ph14050470] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
23 Schiliro C, Firestein BL. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells 2021;10:1056. [PMID: 33946927 DOI: 10.3390/cells10051056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
24 Huang J, Zhao X, Li X, Peng J, Yang W, Mi S. HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma. PLoS Biol 2021;19:e3001197. [PMID: 33905408 DOI: 10.1371/journal.pbio.3001197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chen Z, Chen L, Sun B, Liu D, He Y, Qi L, Li G, Han Z, Zhan L, Zhang S, Zhu K, Luo Y, Chen L, Zhang N, Guo H. LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway. Mol Metab 2021;51:101230. [PMID: 33823318 DOI: 10.1016/j.molmet.2021.101230] [Reference Citation Analysis]
26 Alcázar-Fabra M, Rodríguez-Sánchez F, Trevisson E, Brea-Calvo G. Primary Coenzyme Q deficiencies: A literature review and online platform of clinical features to uncover genotype-phenotype correlations. Free Radic Biol Med 2021;167:141-80. [PMID: 33677064 DOI: 10.1016/j.freeradbiomed.2021.02.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
27 Haney SL, Varney ML, Chhonker Y, Talmon G, Smith LM, Murry DJ, Holstein SA. In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway. Pharmacol Res 2021;167:105528. [PMID: 33667685 DOI: 10.1016/j.phrs.2021.105528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Guerra B, Recio C, Aranda-Tavío H, Guerra-Rodríguez M, García-Castellano JM, Fernández-Pérez L. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy. Front Oncol 2021;11:626971. [PMID: 33718197 DOI: 10.3389/fonc.2021.626971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
29 Manzano-León N, Garcia-Lopez P. Statins as adjuvants in the treatment of ovarian cancer: Controversy and misunderstanding. Eur J Pharmacol 2021;896:173915. [PMID: 33513335 DOI: 10.1016/j.ejphar.2021.173915] [Reference Citation Analysis]
30 Juarez D, Fruman DA. Targeting the Mevalonate Pathway in Cancer. Trends Cancer 2021;7:525-40. [PMID: 33358111 DOI: 10.1016/j.trecan.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Audano M, Pedretti S, Ligorio S, Crestani M, Caruso D, De Fabiani E, Mitro N. "The Loss of Golden Touch": Mitochondria-Organelle Interactions, Metabolism, and Cancer. Cells 2020;9:E2519. [PMID: 33233365 DOI: 10.3390/cells9112519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Du X, Ou Y, Zhang M, Li K, Huang W, Jiang D. The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA. Genes & Diseases 2020. [DOI: 10.1016/j.gendis.2020.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Ortiz N, Díaz C. Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer. Oncol Lett 2020;20:320. [PMID: 33093924 DOI: 10.3892/ol.2020.12183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kobayashi K, Baba K, Kambayashi S, Okuda M. Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells. Vet Comp Oncol 2021;19:99-108. [PMID: 32779819 DOI: 10.1111/vco.12644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Xue L, Qi H, Zhang H, Ding L, Huang Q, Zhao D, Wu BJ, Li X. Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy. Front Oncol 2020;10:1510. [PMID: 32974183 DOI: 10.3389/fonc.2020.01510] [Cited by in Crossref: 8] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
36 Göbel A, Zinna VM, Dell'Endice S, Jaschke N, Kuhlmann JD, Wimberger P, Rachner TD. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer. BMC Cancer 2020;20:703. [PMID: 32727400 DOI: 10.1186/s12885-020-07164-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
37 Xu H, Zhou S, Tang Q, Xia H, Bi F. Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer 2020;1874:188394. [PMID: 32698040 DOI: 10.1016/j.bbcan.2020.188394] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 30.0] [Reference Citation Analysis]
38 Vassalle C, Maltinti M, Sabatino L. Targeting Oxidative Stress for Disease Prevention and Therapy: Where Do We Stand, and Where Do We Go from Here. Molecules 2020;25:E2653. [PMID: 32517368 DOI: 10.3390/molecules25112653] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
39 Wang IH, Huang TT, Chen JL, Chu LW, Ping YH, Hsu KW, Huang KH, Fang WL, Lee HC, Chen CF, Liao CC, Hsieh RH, Yeh TS. Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression. Cancers (Basel) 2020;12:E1088. [PMID: 32349352 DOI: 10.3390/cancers12051088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]